WEALTH ENHANCEMENT ADVISORY SERVICES, LLC

Position in ARWR — Arrowhead Pharmaceuticals, Inc.

CIK 1632972 PLYMOUTH, MN

Position in ARWR

as of Jun 30, 2026 · filed Jul 15, 2026 Compact

Position Value

$1,767,870

+$420,636 QoQ

Shares Held

21,689

+0.9% QoQ

Ownership

0.015%

of shares outstanding

% of Portfolio

0.01%

of 13F equity value

Holder Rank

#206

of 497 holders

Holding Since

Sep 2023

10 quarters on record

Voting authority Sole 0% Shared 0% None 100%

Healthcare · as of Jun 30, 2026

WEALTH ENHANCEMENT ADVISORY SERVICES, LLC holds $166,117,226 across 147 Biotechnology names. ARWR ranks #15 (1.1% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	VRTX	Vertex Pharmaceuticals Inc / Ma	45,889	$22,794,442
2	REGN	Regeneron Pharmaceuticals, Inc.	33,880	$21,125,535
3	INCY	Incyte Corp	151,505	$17,174,606
4	EXEL	Exelixis, Inc.	207,728	$11,302,480
5	RPRX	Royalty Pharma plc	179,888	$10,086,320
6	CORT	Corcept Therapeutics Inc	76,278	$6,632,372
7	HALO	Halozyme Therapeutics, Inc.	70,797	$5,541,281
8	AXSM	Axsome Therapeutics, Inc.	19,919	$4,875,573

10 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$1,767,870	21,689	+0.9%	Shares	Sole	2026-07-15
2026-03-31	$1,347,234	21,487	+13.3%	Shares	Sole	2026-04-08
2025-12-31	$1,258,820	18,961	+25.7%	Shares	Sole	2026-01-08
2025-09-30	$520,212	15,083	-3.2%	Shares	Sole	2025-10-29
2025-06-30	$246,164	15,580	+7.5%	Shares	Sole	2025-07-10
2024-09-30	$280,826	14,498	+79.6%	Shares	Sole	2024-10-24
2024-06-30	$209,843	8,074	-5.4%	Shares	Sole	2024-07-16
2024-03-31	$244,129	8,536	+1.2%	Shares	Sole	2024-04-15
2023-12-31	$258,019	8,432	+8.5%	Shares	Sole	2024-01-30
2023-09-30	$208,806	7,771	—	Shares	Sole	2023-11-13
No filing history on record for this holder in this stock.